WOUNDS Middle East, a division of WOUNDS International publishes a case report on Enluxtra dressings healing a challenging pressure injury in just 3 weeks.
|
International expansion puts Enluxtra in the spotlight in a recent middle eastern publication
Santa Clara, California. -- May 2017 — A new international publication has recently reported on a challenging Stage III tunneling pressure ulcer that was fully healed with Enluxtra Self-Adaptive wound dressings.
| ||
Wounds Middle East, a division of Wounds International has published an article by Abdulkarem Iblasi , Clinical Nurse Manager, and Dr Hussam Eddine Saleh Itani MD MSc that reported an impressive outcome of Enluxtra wound dressing treatment in a patient with serious co-morbidities. The patient’s challenging Stage III pressure ulcer was healed within only 22 days.
The article discusses the main barriers to healing chronic wounds, the conventional treatment approaches and evaluates the results achieved by the Enluxtra dressing treatment. The conclusion is indicative of the many benefits of self-adaptive technology that helped to effectively manage exudate, assist in slough autolysis, decrease bacterial burden, and support granulation in the wound tunnel and epithelialisation of the periwound skin.
One of the principal advantages of Enluxtra dressing is its capacity to absorb any amount of exudate and retain it even under the pressure of body weight – crucial for pressure ulcers – and/or compression wraps – important in patients with leg ulcers.
Exudate management remains a key component to healing chronic wounds, and once achieved, the healing progress advances exponentially. Enluxtra dressings impress with quick and efficient exudate control without overdrying tissues that may still need hydration. Among other benefits are non-medicated remedy of infection, continuous support of natural autolytic debridement, and subsequent reduction of pain an odor.
Self-adaptive technology unique to Enluxtra brand products is being used widely at leading national medical centers, such as UCSF, SFGH, Baylor Health and many others. Enluxtra dressings are manufactured to the highest industry standards, FDA-registered, and covered under Medicare Part B.
The article discusses the main barriers to healing chronic wounds, the conventional treatment approaches and evaluates the results achieved by the Enluxtra dressing treatment. The conclusion is indicative of the many benefits of self-adaptive technology that helped to effectively manage exudate, assist in slough autolysis, decrease bacterial burden, and support granulation in the wound tunnel and epithelialisation of the periwound skin.
One of the principal advantages of Enluxtra dressing is its capacity to absorb any amount of exudate and retain it even under the pressure of body weight – crucial for pressure ulcers – and/or compression wraps – important in patients with leg ulcers.
Exudate management remains a key component to healing chronic wounds, and once achieved, the healing progress advances exponentially. Enluxtra dressings impress with quick and efficient exudate control without overdrying tissues that may still need hydration. Among other benefits are non-medicated remedy of infection, continuous support of natural autolytic debridement, and subsequent reduction of pain an odor.
Self-adaptive technology unique to Enluxtra brand products is being used widely at leading national medical centers, such as UCSF, SFGH, Baylor Health and many others. Enluxtra dressings are manufactured to the highest industry standards, FDA-registered, and covered under Medicare Part B.
About OSNovative Systems
OSNovative Systems, Inc. is a rapidly growing start-up in the Silicon Valley. It is a privately held company, owned, and managed by a team of dedicated professionals. The company develops, manufactures, and sells proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care.
OSNovative Systems, Inc. is in cooperation with a world-leading supplier of raw chemical materials in order to fabricate its products to the highest standards of quality. The company's quality management system has been ISO 13485:2003 certified to adhere to international standards developed for manufacturers of medical devices to ensure that products and services are safe, reliable, and of good quality.
The company’s flagship product, Enluxtra, is the first and only wound dressing of the new self-adaptive class, and is suitable for all wounds at any healing stage. Self-adaptive technology revolutionizes wound care and makes institutional, home-based, and field wound management simple, efficient, and cost effective. The Enluxtra brand is widely recognized by medical professionals in the US and internationally.
OSNovative Systems is headquartered in Santa Clara, Calif. For more information, visit www.anywound.com
About ENLUXTRA:
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email:[email protected]
###
OSNovative Systems, Inc. is a rapidly growing start-up in the Silicon Valley. It is a privately held company, owned, and managed by a team of dedicated professionals. The company develops, manufactures, and sells proprietary devices for advanced wound management, combat/emergency medicine and cosmetic skin care.
OSNovative Systems, Inc. is in cooperation with a world-leading supplier of raw chemical materials in order to fabricate its products to the highest standards of quality. The company's quality management system has been ISO 13485:2003 certified to adhere to international standards developed for manufacturers of medical devices to ensure that products and services are safe, reliable, and of good quality.
The company’s flagship product, Enluxtra, is the first and only wound dressing of the new self-adaptive class, and is suitable for all wounds at any healing stage. Self-adaptive technology revolutionizes wound care and makes institutional, home-based, and field wound management simple, efficient, and cost effective. The Enluxtra brand is widely recognized by medical professionals in the US and internationally.
OSNovative Systems is headquartered in Santa Clara, Calif. For more information, visit www.anywound.com
About ENLUXTRA:
- ENLUXTRA Self-Adaptive Wound Dressing is the first self-regulating super-absorbent fiber dressing with built-in on-demand hydration.
- Innovative self-adaptive technology enables ENLUXTRA to re-start and complete healing of difficult or non-healing wounds.
- ENLUXTRA uses “smart” feedback-driven materials that functionally adapt to match unpredictably changing wound conditions. This adaptability makes ENLUXTRA suitable for wounds of any etiology (including burns), and of any drainage level — from minimal to high.
- ENLUXTRA is designed for long wear time and fewer dressing changes. Its absorbency is approximately 2 times higher than any dressing on the market. Its material locks in the absorbed exudate, and does not release it under pressure, preventing skin maceration. Further, ENLUXTRA supports intensive natural autolytic debridement, and microbial and odor reduction.
- ENLUXTRA dressings significantly decrease treatment time,material, and inventory expenses, reduce cost of care, and help improve quality measures.
Contact Information:
Polina D. Krasnova
Communications and PR Manager
OSNovative Systems, Inc.
Direct Line: 650-483-9938
Toll Free: 888-519-2297 ext. 417
Email:[email protected]
###
